financetom
Business
financetom
/
Business
/
US agency settles with Chicago mortgage firm over racial discrimination claims
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US agency settles with Chicago mortgage firm over racial discrimination claims
Nov 4, 2024 11:28 AM

(Reuters) - The top U.S. consumer financial watchdog agency on Friday said it had reached a settlement in a long-running lawsuit with a Chicago mortgage lender over alleged racial discrimination.

Under the terms of the proposed agreement, Townstone Financial would pay a $105,000 fine into the U.S. Consumer Financial Protection Bureau's victims relief fund.

In a statement on its website, the Pacific Legal Foundation, which represented Townstone, said the company neither admitted nor denied the allegations and settled due to government's superior legal resources. "This case should never have been brought," attorney Steve Simpson said.

WHY IT MATTERS

The CFPB says the enforcement action follows the agency's July legal victory before the U.S. Seventh Circuit Court of Appeals, which gave it new freedom to fight racial discrimination not only in lending but also in marketing of loans. It is the agency's second action on racial bias in the mortgage industry in less than three weeks.

KEY QUOTE

"The CFPB's lawsuit against Townstone Financial included a major appellate court victory that makes clear that people are protected from illegal redlining even before they submit their application," CFPB Director Rohit Chopra said in a statement.

CONTEXT

In 2020, the CFPB accused Townstone Financial of discouraging Black people from applying for mortgages and avoiding the credit needs of African American neighborhoods in the Chicago area. In weekly marketing radio shows and podcasts, the company allegedly disparaged predominantly Black neighborhoods as crime ridden and the "jungle."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved